Store Optician Access
09/04/2015 - Projects

Eye Poc European Project

Excellence in Research initiated by Horus Pharma laboratories and Bioftalmik was recognized by the European Commission through the support of the European Union's Horizon 2020 programme, an international program that supports innovative small and medium-sized enterprises.

Horus Pharma laboratories obtained European Economic Community SME Phase 1 financial support for its Eye PoC project.

Project title

Clinical validation of a new diagnostic and monitoring PoC medical device based on quantification of biomarkers in tear fluids to improve the quality of eye health care.

Participants

  • Horus Pharma (Coordinator)
  • Bioftalmik Applied Research (Participant)

This project has received funding from the European Union’s Horizon 2020 Research and Innovation programme under grant agreement No 652132

 

Europe

Horus Pharma has been granted with European Economic Community SME Phase 1 Financial support for its Eye PoC project.

Title of Project : Clinical validation of a new diagnostic and monitoring PoC medical device based on quantification of biomarkers in tear fluids to improve the quality of eye health care

Participants : Horus Pharma laboratories (Coordinator) and Bioftalmik Applied Research (Participant)

This Project has received Funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 652132.